Search Results

With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.

Providence Medical Technology, Inc., an innovator in solutions for spinal surgery, announces that the U.S. Food and Drug Administration has cleared the use of the CORUS™ Navigation Access System for use with the CORUS Spinal System during spinal surgery.

Lineage Cell Therapeutics, Inc. today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium (“2nd SCIIS”).

ONWARD Medical N.V., the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury, announces the publication of global Up-LIFT pivotal trial results in Nature Medicine.

Medtronic plc today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.